1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2016-2027)
2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Regions
2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Share by Regions (2016-2021)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2022-2027)
2.3 Irritable Bowel Syndrome (IBS) Industry Dynamic
2.3.1 Irritable Bowel Syndrome (IBS) Market Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2016-2021)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2021)
3.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2020
3.5 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2022-2027)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2016-2021)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
6.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type
6.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
6.2.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
6.2.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application
6.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
6.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
6.3.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country
6.4.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
6.4.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
7.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
7.2.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
7.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
7.3.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
7.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type
8.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application
8.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
8.4.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
9.2.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
9.2.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
9.2.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
9.3.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
9.3.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
9.3.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
9.4.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
9.4.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
10.2.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
10.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
10.4.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Details
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.5.5 Sebela Pharmaceuticals Inc Recent Development
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Details
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.6.5 Astellas Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
